Cita APA (7a ed.)

(2018). Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys.

Cita Chicago Style (17a ed.)

Histamine H4 Receptor as a Novel Therapeutic Target for the Treatment of Leydig-cell Tumours in Prepubertal Boys. 2018.

Cita MLA (8a ed.)

Histamine H4 Receptor as a Novel Therapeutic Target for the Treatment of Leydig-cell Tumours in Prepubertal Boys. 2018.